News about Global Pharma

SPARC Submits IND Application for SBO-154 to USFDA

Sun Pharma Advanced Research Company Ltd. (SPARC) has submitted an IND application to the US FDA for SBO-154, a novel antibody-drug conjugate (ADC) targeting advanced solid tumours.

Global Pharma | 31/03/2025 | By Aishwarya |  387

Spyre Therapeutics Initiates Dosing of First Participant in Phase 1 Trial of SPY003

The SPY003 Phase 1 Trial (NCT06873724) is a double-blind, placebo-controlled single-ascending dose study in healthy volunteers.

Global Pharma | 31/03/2025 | By Aishwarya |  353

IASO Bio Gets Approval of New Drug Application for Equecabtagene Autoleucel

Equecabtagene Autoleucel (FUCASO) was approved by China's National Medical Products Administration (NMPA) on June 30, 2023, for treating adult patients with relapsed or refractory multiple myeloma (R/RMM) who have received three or more lines of prior therapies, including at least one proteasome inhibitor and an immunomodulatory agent.

Global Pharma | 31/03/2025 | By Aishwarya |  248

Suven Pharmaceuticals Secures NCLT Approval for Merger with Cohance Lifesciences

Over 99.9994 percent of Suven’s equity shareholders and 99.967 percent of Cohance’s shareholders voted in favor of the Scheme of Amalgamation during meetings held on November 28, 2024.

Global Pharma | 31/03/2025 | By Aishwarya |  756

Visby Medical Receives FDA De Novo Authorization for OTC Women's Sexual Health Test

Visby Medical announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for the Visby Medical Women's Sexual Health Test for Over the Counter (OTC) use. This groundbreaking test enables reliable, rapid, and private at-home testing for Chlamydia, Gonorrhea, and Trichomoniasis—the three most common curable STIs.

Global Pharma | 29/03/2025 | By Manvi |  253

FDA Approves Novel Treatment for Hemophilia A or B

The FDA has approved Qfitlia (fitusiran) for routine prophylaxis in hemophilia A and B patients aged 12 and older, offering a less frequent dosing option by targeting antithrombin to enhance clotting and reduce bleeding episodes.

Global Pharma | 29/03/2025 | By Manvi |  262

SSI Hits New Milestone with Cardiac Telesurgery Performed from North to South Across 2,000 Km

Made possible by the advanced SSI Mantra 3 Surgical Robotic System, this landmark procedure bridged a 2,000-kilometer distance between SS Innovations' headquarters in Gurugram and Aster CMI Hospital in Bengaluru with imperceptible latency.

Global Pharma | 29/03/2025 | By Aishwarya |  584

Bio-Thera Signs Exclusive Commercialization Deal with Dr. Reddy's for BAT2206 and BAT2506

Under the agreement, Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506. Dr. Reddy's will be responsible for seeking regulatory approvals as well as commercialization in the licensed territories in Southeast Asia, including Cambodia, Indonesia, Malaysia, Philippines, Thailand, Vietnam.

Global Pharma | 29/03/2025 | By Aishwarya |  267

Curium Acquires Monrol to Expand Lutetium-177 Capacity

Monrol complements and adds to Curium’s extensive research & development (R&D) capabilities as it continues to expand its portfolio and pipeline of innovative theranostic products.

Global Pharma | 29/03/2025 | By Aishwarya |  287

TOMI Environmental Solutions and PBSC to Enhance Disinfection Solutions

Through this OEM agreement, TOMI will now offer pass-through hatches and chambers integrated with iHP, specifically designed for optimized decontamination cycles.

Global Pharma | 29/03/2025 | By Aishwarya |  215